Circulating endothelial microparticles as a marker of cerebrovascular disease
暂无分享,去创建一个
J. Roh | K. Chu | Soon-Tae Lee | Manho Kim | Keun-Hwa Jung | Jin-Hee Kim | Hee‐Kwon Park | Jae-Jun Bahn | Dong-Hyun Kim | Sang Kun Lee | Jin‐Hee Kim
[1] C. Lindsell,et al. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[2] Y. Shinohara,et al. Stroke Risk of Asymptomatic Intra- and Extracranial Large-Artery Disease in Apparently Healthy Adults , 2006, Cerebrovascular Diseases.
[3] L. Horstman,et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. , 2006, The American journal of cardiology.
[4] A. Baird,et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome , 2006, Journal of thrombosis and haemostasis : JTH.
[5] J. Roh,et al. Correlation of Coronary and Cerebral Atherosclerosis: Difference between Extracranial and Intracranial Arteries , 2006, Cerebrovascular Diseases.
[6] Nikos Werner,et al. Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[7] P. Lee,et al. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[8] L. Horstman,et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. , 2005, Journal of the American College of Cardiology.
[9] S. Virani,et al. Postprandial Hypertriglyceridemia Increases Circulating Levels of Endothelial Cell Microparticles , 2004, Circulation.
[10] R. Nieuwland,et al. Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.
[11] R. Nieuwland,et al. Cellular microparticles: new players in the field of vascular disease? , 2004, European journal of clinical investigation.
[12] Turgay Dalkara,et al. Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia , 2004, Stroke.
[13] L. Horstman,et al. Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.
[14] M. Ferrari,et al. Migraine as a risk factor for subclinical brain lesions. , 2004, JAMA.
[15] J. Freyssinet. Cellular microparticles: what are they bad or good for? , 2003, Journal of thrombosis and haemostasis : JTH.
[16] L. Horstman,et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.
[17] L. Horstman,et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.
[18] N. Suwanwela,et al. Risk Factors for Atherosclerosis of Cervicocerebral Arteries: Intracranial versus Extracranial , 2003, Neuroepidemiology.
[19] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[20] C Guijarro,et al. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.
[21] A. Tedgui,et al. Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.
[22] B. McManus,et al. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. , 2001, Journal of molecular and cellular cardiology.
[23] A. Minagar,et al. Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.
[24] L. Horstman,et al. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease , 2001, British journal of haematology.
[25] H. A. Smith,et al. A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.
[26] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[27] J. Freyssinet,et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.
[28] G. Grau,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.
[29] P. Sandercock,et al. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. , 1999, Stroke.
[30] A. Fox,et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trail. , 1999, Stroke.
[31] S. Nakamura,et al. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. , 1998, Thrombosis research.
[32] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[33] A. Paetau,et al. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. , 1996, Circulation.
[34] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[35] J. Neefjes,et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.
[36] D. Sackett,et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.